Edition:
United States

People: Acura Pharmaceuticals Inc (ACUR.O)

ACUR.O on Consolidated Issue listed on NASDAQ Capital Market

1.97USD
22 Jul 2016
Change (% chg)

$-0.09 (-4.37%)
Prev Close
$2.06
Open
$2.00
Day's High
$2.02
Day's Low
$1.93
Volume
19,807
Avg. Vol
36,071
52-wk High
$4.34
52-wk Low
$1.61

Thangaraj, Immanuel 

Mr. Immanuel Thangaraj Independent Director of Acura Pharmaceutical Technologies, Inc. since December, 2002. Mr. Thangaraj has been a Managing Director of Essex Woodlands Health Ventures, a venture capital firm specializing in the healthcare industry, since 1997. Prior to joining Essex Woodlands Health Ventures, he helped establish a telecommunication services company, for which he served as its CEO. Mr. Thangaraj holds a Bachelor of Arts and a Masters in Business Administration from the University of Chicago.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Jones

503,424

Peter Clemens

363,160

Robert Seiser

196,948

J. Bradley Rivet

209,422

Albert Brzeczko

351,528

James Emigh

196,948
As Of  30 Dec 2014